BeyondSpring Inc

NASDAQ:BYSI USA Biotechnology
Market Cap
$72.19 Million
Market Cap Rank
#20775 Global
#7504 in USA
Share Price
$1.79
Change (1 day)
+2.87%
52-Week Range
$1.09 - $3.40
All Time High
$48.35
About

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. It operates through two segments: Plinabulin pipeline and TPD platform. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-canc… Read more

BeyondSpring Inc (BYSI) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.217x

Based on the latest financial reports, BeyondSpring Inc (BYSI) has a cash flow conversion efficiency ratio of 0.217x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.29 Million) by net assets ($-19.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

BeyondSpring Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how BeyondSpring Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

BeyondSpring Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BeyondSpring Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for BeyondSpring Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of BeyondSpring Inc from 2014 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $-14.29 Million $-16.44 Million 1.151x +63.93%
2023-12-31 $-23.46 Million $-16.47 Million 0.702x -92.50%
2022-12-31 $-3.01 Million $-28.15 Million 9.362x +514.63%
2021-12-31 $20.92 Million $-47.24 Million -2.258x -373.93%
2020-12-31 $91.82 Million $-43.74 Million -0.476x +69.21%
2019-12-31 $31.13 Million $-48.16 Million -1.547x -136.33%
2018-12-31 $-9.38 Million $-39.95 Million 4.259x +514.63%
2017-12-31 $28.04 Million $-28.80 Million -1.027x +7.78%
2016-12-31 $12.30 Million $-13.70 Million -1.114x -63.72%
2015-12-31 $9.66 Million $-6.57 Million -0.680x -657.57%
2014-12-31 $-9.39 Million $-1.15 Million 0.122x --